News
Videos
Conferences
Events
Resources
Subscribe

News|Videos|May 23, 2016

Immunotherapy Versus Targeted Therapy

Episodes in this series

EP. 1 Distinguishing Melanoma From Other Skin Cancers

EP. 1 Distinguishing Melanoma From Other Skin Cancers

EP. 2 Detecting Melanoma That Has Spread

EP. 2 Detecting Melanoma That Has Spread

EP. 3 Understanding Adjuvant Therapy in Melanoma

EP. 3 Understanding Adjuvant Therapy in Melanoma

EP. 4 Immunotherapy Versus Targeted Therapy

EP. 4 Immunotherapy Versus Targeted Therapy

EP. 5 Considerations Prior to Start of Therapy

EP. 5 Considerations Prior to Start of Therapy

EP. 6 Top Concerns of Patients

EP. 6 Top Concerns of Patients

EP. 7 Additional Approaches in Advanced Melanoma

EP. 7 Additional Approaches in Advanced Melanoma

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Image of woman.

The Benefits of a Pet When Dealing With Cancer

February 2nd 2026

The FDA accepted a new drug application for zanzalintinib plus immunotherapy for some previously treated colorectal cancers: © stock.adobe.com.

FDA to Review New Drug Combo for Previously Treated Metastatic Colorectal Cancer

February 2nd 2026

Image of man.

Expert Insights: FDA Approval of Lymphir for Cutaneous T-Cell Lymphoma

BySpencer Feldman

February 2nd 2026

A study found that a blood test detecting ctDNA after surgery more accurately predicts recurrence and survival in patients with stage 3 colon cancer: © stock.adobe.com.

Blood Test After Surgery May Predict Colon Cancer Recurrence Risk

February 2nd 2026

A real-world study found Erleada reduced the risk of death compared with darolutamide in patients with metastatic castration-sensitive prostate cancer: © stock.adobe.com.

Erleada Shows Survival Advantage in Real-World Study of Metastatic Prostate Cancer

February 2nd 2026

Trending on CURE

Biotin Supplements May Complicate Cancer Care, Research Shows

Most Patients With HER2+ Breast Cancer Miss Standard Treatment, Study Shows

Biotin, Lab Interference and Safer Options for Cancer-Related Hair Loss

What MRD Testing Can Mean for Patients With Breast Cancer and Survivors

Key GI Cancer Advances from the 2026 ASCO Symposium